Clinical Trial Update: Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating late surfactant to prevent bronchopulmonary dysplasia has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Late surfactant

Snippet

Sponsor: Roberta Ballard | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED | Results posted: 2021-05-13